{"gene":"TMPRSS6","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":2008,"finding":"TMPRSS6 (matriptase-2) is required to sense iron deficiency and suppress hepcidin (Hamp) transcription; overexpression of normal TMPRSS6 suppresses activation of the Hamp promoter, and the TMPRSS6 cytoplasmic domain mediates Hamp suppression via proximal promoter elements. Loss-of-function (splicing defect) in mice causes microcytic anemia due to high hepcidin and reduced dietary iron absorption.","method":"Chemically induced mouse mutant (mask), overexpression of TMPRSS6, promoter assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — foundational loss-of-function mouse model plus promoter functional assays, replicated in subsequent studies","pmids":["18451267"],"is_preprint":false},{"year":2008,"finding":"TMPRSS6/matriptase-2 inhibits hepcidin activation by cleaving membrane hemojuvelin (HJV) at the plasma membrane; the serine protease domain is required for cleavage activity, the IRIDA patient mutant R774C shows decreased cleavage capacity, and the ectodomain of matriptase-2 mediates interaction with HJV.","method":"Cell-based cleavage assay, domain deletion mutants, patient mutant functional characterization, zebrafish overexpression","journal":"Cell Metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro cleavage assays with domain mutants, multiple orthogonal methods, replicated across studies","pmids":["18976966"],"is_preprint":false},{"year":2008,"finding":"A truncating TMPRSS6 mutation in humans causes inappropriately elevated hepcidin levels, leading to defective iron absorption and iron-refractory iron-deficiency anemia (IRIDA), confirming the inhibitory role of TMPRSS6 on hepcidin synthesis in humans.","method":"Linkage analysis, gene sequencing, serum/urinary hepcidin measurement in patients","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 2 — human genetic loss-of-function with functional hepcidin measurements, replicated independently","pmids":["18603562"],"is_preprint":false},{"year":2010,"finding":"TMPRSS6 down-regulates the BMP-SMAD signaling pathway to control hepcidin expression; mice deficient in both Tmprss6 and hemojuvelin (Hjv) show markedly decreased hepcidin and Id1 mRNA and develop systemic iron overload similar to Hjv-deficient mice alone, placing Tmprss6 downstream of Hjv in the BMP/Smad pathway.","method":"Genetic epistasis in double-knockout mice (Tmprss6−/−/Hjv−/−), hepatic gene expression analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — clean genetic epistasis with double-knockout mice and defined molecular readouts","pmids":["20200349"],"is_preprint":false},{"year":2010,"finding":"TMPRSS6 expression is upregulated by hypoxia-inducible factors (HIF-1α and HIF-2α) in hepatic cell lines; HIF-dependent up-regulation of TMPRSS6 increases membrane HJV shedding and decreases hepcidin promoter responsiveness to BMP signaling.","method":"Hypoxia treatment of hepatic cell lines, HIF pathway activation/inhibition, HJV shedding assays, hepcidin promoter reporter assay","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays in a single study, not yet independently replicated","pmids":["20966077"],"is_preprint":false},{"year":2010,"finding":"A TMPRSS6 mutation (Y141C) in the SEA domain prevents autocatalytic self-activation of the protease; the mutant localizes normally and binds HJV but cannot auto-catalytically activate itself, resulting in increased hepcidin mRNA expression.","method":"Patient mutation characterization, cell transfection, subcellular localization, HJV binding assay, hepcidin mRNA measurement","journal":"The Biochemical Journal","confidence":"High","confidence_rationale":"Tier 1–2 — mechanistic characterization of auto-activation with functional validation of catalytic consequence","pmids":["20704562"],"is_preprint":false},{"year":2011,"finding":"TMPRSS6 undergoes constitutive clathrin/AP-2-dependent, dynamin-dependent endocytosis in hepatic cells; internalized TMPRSS6 transits through early endosomes to lysosomes. Mutations in the N-terminal cytoplasmic domain that block endocytosis keep TMPRSS6 at the cell surface, resulting in sustained HJV cleavage and significantly decreased hepcidin production.","method":"Cell surface labeling, co-localization with clathrin/AP-2 markers, dynamin inhibition, site-directed mutagenesis of cytoplasmic internalization signals, hepcidin promoter assay","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — mechanistic dissection of internalization pathway with mutagenesis and functional hepcidin readout","pmids":["21724843"],"is_preprint":false},{"year":2011,"finding":"BMP6 and iron stimulate TMPRSS6 expression at the mRNA and protein levels via the BMP-SMAD pathway, with inhibitor of DNA binding 1 (ID1) identified as the key downstream element; TMPRSS6 upregulation by BMP6/iron increases matriptase-2 activity, HJV cleavage, and reduces hepcidin promoter responsiveness—a negative feedback loop.","method":"BMP6 treatment in vitro, neutralizing antibody injection in mice, TMPRSS6 mRNA/protein/activity assays, chromatin and promoter analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in vitro and in vivo","pmids":["21622652"],"is_preprint":false},{"year":2011,"finding":"The TMPRSS6 SNP rs855791 (V736A) is a functional variant: the 736A isoform inhibits hepcidin more efficiently than 736V in vitro and is associated with lower hepcidin levels and higher iron parameters in a genotyped population.","method":"In vitro overexpression of TMPRSS6 V736A vs V736V, hepcidin promoter assay, population genotyping with serum hepcidin measurements","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro functional assay combined with population phenotyping in one study","pmids":["21873547"],"is_preprint":false},{"year":2013,"finding":"Inflammation down-regulates TMPRSS6 expression in vitro and in vivo through decreased STAT5 phosphorylation; STAT5 directly binds a STAT5 element on the Tmprss6 promoter and positively regulates its transcription. Loss of TMPRSS6 via this mechanism contributes to inflammation-induced hepcidin elevation.","method":"IL-6 treatment of hepatoma cells, LPS injection in mice, STAT5 ChIP and promoter binding assay, phosphorylation analysis","journal":"PLoS One","confidence":"High","confidence_rationale":"Tier 2 — direct promoter binding demonstrated by ChIP, validated in vitro and in vivo","pmids":["24376517"],"is_preprint":false},{"year":2015,"finding":"TMPRSS6 cleaves hemojuvelin at arginine residues 121 and 326 in both the full-length and heterodimeric HJV isoforms; mutagenesis of these arginines abolishes or alters the cleavage fragment pattern, and molecular dynamics modeling supports their solvent-accessibility in the HJV structure.","method":"Site-directed mutagenesis of HJV arginine residues, co-expression with TMPRSS6, fragment analysis in conditioned media, molecular dynamics simulation","journal":"Journal of Cellular and Molecular Medicine","confidence":"High","confidence_rationale":"Tier 1–2 — systematic mutagenesis of cleavage sites combined with structural modeling","pmids":["25704252"],"is_preprint":false},{"year":2014,"finding":"IRIDA patient missense mutations in TMPRSS6 impair matriptase-2 autocatalytic activation and/or its ability to cleave membrane HJV and inhibit HJV-dependent hepcidin activation; genotype-phenotype analysis shows patients with two nonsense mutations have more severe anemia and higher hepcidin than those with partial-loss mutations.","method":"In vitro expression of IRIDA patient mutants, autocatalytic activation assay, HJV cleavage assay, hepcidin promoter reporter assay, genotype-phenotype correlation in patients","journal":"Human Mutation","confidence":"High","confidence_rationale":"Tier 1–2 — systematic functional characterization of multiple patient mutations with multiple orthogonal assays","pmids":["25156943"],"is_preprint":false},{"year":2012,"finding":"Deletion of Tmprss6 in Hbb(th3/+) β-thalassemia mice upregulates hepcidin, inhibits iron absorption and recycling, reduces ineffective erythropoiesis, splenomegaly, and iron loading; Tmprss6 is essential for hepcidin inhibition by the erythroid regulator in thalassemia.","method":"Double-knockout mouse model (Tmprss6−/−/Hbbth3/+), hematological and iron parameter analysis, hepcidin mRNA measurement","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — clean genetic model with defined mechanistic and phenotypic readouts, independently replicated","pmids":["22490684"],"is_preprint":false},{"year":2014,"finding":"Genetic epistasis shows that hepatic TFR2 acts upstream of TMPRSS6 in the hepcidin-regulation pathway; Hfe and Tfr2 are not substrates for Tmprss6 protease activity (double mutant mice show Tmprss6-phenotype dominance for hepcidin), while erythroid Tfr2 modulates erythropoiesis independently of hepcidin.","method":"Double-knockout mouse models (Tmprss6−/−/Tfr2−/− and Tmprss6−/−/Tfr2LCKO), hepcidin and iron parameter analysis","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with tissue-specific knockout mice and defined pathway placement","pmids":["24658816"],"is_preprint":false},{"year":2019,"finding":"Peptidomimetic and non-peptidic inhibitors of TMPRSS6 block TMPRSS6-dependent hemojuvelin cleavage in hepatocytes and increase HAMP expression and secreted hepcidin levels in HepG2 cells and human primary hepatocytes.","method":"TMPRSS6 inhibitor treatment of hepatic cell lines and primary hepatocytes, HJV cleavage assay, hepcidin mRNA and protein measurement","journal":"Cell Chemical Biology","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic inhibition with mechanistic substrate (HJV) cleavage readout in human primary cells","pmids":["31543462"],"is_preprint":false}],"current_model":"TMPRSS6 (matriptase-2) is a type II transmembrane serine protease expressed primarily in hepatocytes that autocatalytically activates itself and then cleaves membrane hemojuvelin (at Arg121 and Arg326) via dynamin-dependent, clathrin-mediated endocytic cycling at the cell surface, thereby disrupting BMP-SMAD signaling and suppressing transcription of the iron-regulatory hormone hepcidin; its expression is positively regulated by BMP6/iron (via SMAD/ID1) and growth hormone (via STAT5), and negatively regulated by inflammation (via reduced STAT5 phosphorylation), placing TMPRSS6 as the central brake on hepcidin production that permits adequate dietary iron absorption during iron deficiency."},"narrative":{"teleology":[{"year":2008,"claim":"Identification of TMPRSS6 as the critical sensor of iron deficiency that suppresses hepcidin transcription resolved how the body permits dietary iron absorption under low-iron conditions; loss of function causes microcytic anemia from unchecked hepcidin production.","evidence":"Forward genetic screen in ENU-mutagenized mice (mask phenotype), overexpression and promoter assays","pmids":["18451267"],"confidence":"High","gaps":["Molecular substrate of TMPRSS6 not yet identified at this stage","Mechanism of hepcidin promoter suppression unknown"]},{"year":2008,"claim":"Demonstration that TMPRSS6 cleaves membrane hemojuvelin via its serine protease domain identified the direct substrate linking the protease to BMP-SMAD-hepcidin signaling, and showed that IRIDA mutations impair this cleavage.","evidence":"Cell-based HJV cleavage assay with domain-deletion and patient (R774C) mutants, zebrafish overexpression","pmids":["18976966","18603562"],"confidence":"High","gaps":["Specific cleavage sites on HJV not mapped","In vivo confirmation of HJV as the sole relevant substrate not established"]},{"year":2010,"claim":"Genetic epistasis placing TMPRSS6 downstream of HJV in the BMP-SMAD pathway clarified that the protease acts by eliminating a required BMP co-receptor rather than signaling independently.","evidence":"Double-knockout mice (Tmprss6−/−/Hjv−/−) with hepatic gene expression profiling","pmids":["20200349"],"confidence":"High","gaps":["Whether TMPRSS6 cleaves additional BMP pathway components not resolved","Contribution of soluble HJV fragments to residual signaling unclear"]},{"year":2010,"claim":"Discovery that the SEA-domain IRIDA mutation Y141C abolishes autocatalytic activation while preserving HJV binding established that self-activation is a prerequisite for substrate cleavage and a distinct mechanistic step.","evidence":"Patient mutant characterization with subcellular localization, HJV binding, and hepcidin mRNA assays in transfected cells","pmids":["20704562"],"confidence":"High","gaps":["Structural basis of autocatalytic cleavage not determined","Whether additional cofactors assist activation unknown"]},{"year":2011,"claim":"Elucidation of constitutive clathrin/AP-2/dynamin-dependent endocytosis of TMPRSS6 showed that intracellular trafficking limits cell-surface lifetime of the protease and thereby tunes the magnitude of HJV cleavage and hepcidin suppression.","evidence":"Surface labeling, colocalization with clathrin/AP-2 markers, dynamin inhibition, cytoplasmic domain mutagenesis, hepcidin promoter assays in hepatic cells","pmids":["21724843"],"confidence":"High","gaps":["Specific internalization motif(s) in cytoplasmic tail not fully mapped","Whether endosomal TMPRSS6 retains catalytic activity not tested"]},{"year":2011,"claim":"BMP6/iron-driven upregulation of TMPRSS6 via SMAD/ID1 revealed a negative-feedback loop: the same signal that induces hepcidin also amplifies its suppressor, explaining how hepcidin is fine-tuned rather than simply switched on.","evidence":"BMP6 treatment in vitro, anti-BMP6 antibody injection in mice, TMPRSS6 mRNA/protein/activity assays, promoter analysis","pmids":["21622652"],"confidence":"High","gaps":["Quantitative contribution of feedback loop to steady-state hepcidin levels in vivo not modeled","Whether other BMP ligands contribute similarly unclear"]},{"year":2012,"claim":"Deletion of Tmprss6 in β-thalassemia mice showed that the protease is required for pathological hepcidin suppression by the expanded erythroid compartment, establishing TMPRSS6 as a therapeutic target for iron-loading anemias.","evidence":"Double mutant mice (Tmprss6−/−/Hbbth3/+), hematological, iron, and hepcidin analysis","pmids":["22490684"],"confidence":"High","gaps":["Nature of the erythroid signal that acts through TMPRSS6 not identified","Degree of hepcidin restoration needed for therapeutic benefit not quantified"]},{"year":2013,"claim":"Identification of STAT5 as a direct positive transcriptional regulator of TMPRSS6, suppressed during inflammation via reduced STAT5 phosphorylation, explained how inflammatory signals elevate hepcidin partly by removing the TMPRSS6 brake.","evidence":"IL-6 treatment of hepatoma cells, LPS injection in mice, STAT5 ChIP on Tmprss6 promoter, phosphorylation analysis","pmids":["24376517"],"confidence":"High","gaps":["Relative contribution of TMPRSS6 down-regulation versus direct IL-6/STAT3-driven hepcidin induction during inflammation not dissected","Growth hormone/STAT5 axis regulation of TMPRSS6 in vivo not independently confirmed"]},{"year":2014,"claim":"Systematic functional analysis of IRIDA mutations showed that missense variants impair either autocatalytic activation or HJV cleavage or both, and that genotype severity correlates with phenotype, solidifying the structure-function framework for clinical genetics.","evidence":"In vitro expression of multiple patient mutants, autocatalytic activation, HJV cleavage, and hepcidin promoter reporter assays, genotype-phenotype correlation","pmids":["25156943"],"confidence":"High","gaps":["Crystal structure of TMPRSS6 protease domain not available to map mutation effects structurally","Residual activity thresholds for clinical disease not defined"]},{"year":2015,"claim":"Mapping HJV cleavage to Arg121 and Arg326 defined the precise sites through which TMPRSS6 inactivates the BMP co-receptor, providing the first substrate-level resolution.","evidence":"Systematic arginine-to-alanine mutagenesis of HJV, fragment analysis in conditioned media, molecular dynamics simulation","pmids":["25704252"],"confidence":"High","gaps":["Whether these are the only physiologically relevant cleavage sites in vivo not confirmed","Kinetic parameters of cleavage not measured"]},{"year":2019,"claim":"Small-molecule inhibitors of TMPRSS6 recapitulated loss-of-function effects—blocking HJV cleavage and raising hepcidin—in human primary hepatocytes, providing pharmacological proof of concept for targeting the protease.","evidence":"Peptidomimetic and non-peptidic inhibitor treatment of HepG2 cells and human primary hepatocytes, HJV cleavage and hepcidin assays","pmids":["31543462"],"confidence":"High","gaps":["In vivo efficacy and selectivity of inhibitors not demonstrated","Off-target effects on other TTSP family members not assessed"]},{"year":null,"claim":"A high-resolution crystal structure of TMPRSS6, the complete repertoire of physiological substrates beyond HJV, and the identity of the erythroid signal that acts through TMPRSS6 in ineffective erythropoiesis remain to be established.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal or cryo-EM structure of TMPRSS6","Whether substrates other than HJV contribute to hepcidin regulation is unresolved","Identity of erythroid factor that requires TMPRSS6 for hepcidin suppression is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,5,10,11,14]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,5,6]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[6]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,7]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,2,12]}],"complexes":[],"partners":["HFE2","STAT5A","SMAD4","ID1"],"other_free_text":[]},"mechanistic_narrative":"TMPRSS6 (matriptase-2) is a hepatocyte-expressed type II transmembrane serine protease that functions as the principal negative regulator of hepcidin, the master hormone controlling systemic iron homeostasis. TMPRSS6 undergoes autocatalytic self-activation requiring an intact SEA domain, then cleaves membrane hemojuvelin (HJV) at Arg121 and Arg326, thereby disrupting BMP-SMAD signaling and suppressing hepcidin (HAMP) transcription [PMID:18976966, PMID:25156943, PMID:25704252]. The protease cycles through the plasma membrane via clathrin/AP-2- and dynamin-dependent endocytosis to lysosomes; blocking internalization prolongs surface residence and enhances HJV cleavage [PMID:21724843]. Its expression is induced by BMP6/iron through SMAD/ID1 as a negative-feedback loop and by STAT5, while inflammation suppresses TMPRSS6 via reduced STAT5 phosphorylation; loss-of-function mutations cause iron-refractory iron-deficiency anemia (IRIDA) in humans [PMID:21622652, PMID:24376517, PMID:18603562]."},"prefetch_data":{"uniprot":{"accession":"Q8IU80","full_name":"Transmembrane protease serine 6","aliases":["Matriptase-2"],"length_aa":811,"mass_kda":90.0,"function":"Membrane-bound serine protease (PubMed:18976966, PubMed:20518742, PubMed:25156943, PubMed:25588876). Through the cleavage of cell surface hemojuvelin (HJV), a regulator of the expression of the iron absorption-regulating hormone hepicidin/HAMP, plays a role in iron homeostasis (PubMed:18408718, PubMed:18976966, PubMed:25156943)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q8IU80/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TMPRSS6","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TMPRSS6","total_profiled":1310},"omim":[{"mim_id":"614193","title":"TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2","url":"https://www.omim.org/entry/614193"},{"mim_id":"613284","title":"HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3","url":"https://www.omim.org/entry/613284"},{"mim_id":"610560","title":"PROTEASE, SERINE, 36; PRSS36","url":"https://www.omim.org/entry/610560"},{"mim_id":"610477","title":"TRANSMEMBRANE PROTEASE, SERINE 9; TMPRSS9","url":"https://www.omim.org/entry/610477"},{"mim_id":"609862","title":"TRANSMEMBRANE PROTEASE, SERINE 6; TMPRSS6","url":"https://www.omim.org/entry/609862"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"liver","ntpm":129.5}],"url":"https://www.proteinatlas.org/search/TMPRSS6"},"hgnc":{"alias_symbol":["FLJ30744","MT2"],"prev_symbol":[]},"alphafold":{"accession":"Q8IU80","domains":[{"cath_id":"3.30.70.960","chopping":"84-208","consensus_level":"medium","plddt":87.0838,"start":84,"end":208},{"cath_id":"2.60.120.290","chopping":"213-331","consensus_level":"medium","plddt":87.9065,"start":213,"end":331},{"cath_id":"2.60.120.290","chopping":"338-458","consensus_level":"high","plddt":91.2049,"start":338,"end":458},{"cath_id":"2.40.10.10","chopping":"582-811","consensus_level":"medium","plddt":91.3673,"start":582,"end":811}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IU80","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IU80-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IU80-F1-predicted_aligned_error_v6.png","plddt_mean":84.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TMPRSS6","jax_strain_url":"https://www.jax.org/strain/search?query=TMPRSS6"},"sequence":{"accession":"Q8IU80","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IU80.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IU80/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IU80"}},"corpus_meta":[{"pmid":"2992081","id":"PMC_2992081","title":"Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.","date":"1985","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2992081","citation_count":898,"is_preprint":false},{"pmid":"16217123","id":"PMC_16217123","title":"Functional MT1 and MT2 melatonin receptors in mammals.","date":"2005","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/16217123","citation_count":640,"is_preprint":false},{"pmid":"26514204","id":"PMC_26514204","title":"MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.","date":"2015","source":"Annual review of pharmacology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/26514204","citation_count":466,"is_preprint":false},{"pmid":"18451267","id":"PMC_18451267","title":"The serine protease TMPRSS6 is required to sense iron deficiency.","date":"2008","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18451267","citation_count":462,"is_preprint":false},{"pmid":"1176436","id":"PMC_1176436","title":"Metabolism of toluene and xylenes by Pseudomonas (putida (arvilla) mt-2: evidence for a new function of the TOL plasmid.","date":"1975","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/1176436","citation_count":453,"is_preprint":false},{"pmid":"18976966","id":"PMC_18976966","title":"The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.","date":"2008","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18976966","citation_count":437,"is_preprint":false},{"pmid":"12764576","id":"PMC_12764576","title":"New selective ligands of human cloned melatonin MT1 and MT2 receptors.","date":"2003","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12764576","citation_count":202,"is_preprint":false},{"pmid":"23524968","id":"PMC_23524968","title":"Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23524968","citation_count":194,"is_preprint":false},{"pmid":"23223430","id":"PMC_23223430","title":"An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23223430","citation_count":173,"is_preprint":false},{"pmid":"15266022","id":"PMC_15266022","title":"Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers.","date":"2004","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15266022","citation_count":167,"is_preprint":false},{"pmid":"15617532","id":"PMC_15617532","title":"Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.","date":"2005","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/15617532","citation_count":164,"is_preprint":false},{"pmid":"25726952","id":"PMC_25726952","title":"Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain.","date":"2015","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/25726952","citation_count":144,"is_preprint":false},{"pmid":"18603562","id":"PMC_18603562","title":"A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.","date":"2008","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/18603562","citation_count":143,"is_preprint":false},{"pmid":"22490684","id":"PMC_22490684","title":"Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22490684","citation_count":137,"is_preprint":false},{"pmid":"24228714","id":"PMC_24228714","title":"MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.","date":"2013","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24228714","citation_count":131,"is_preprint":false},{"pmid":"11564683","id":"PMC_11564683","title":"Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes.","date":"2001","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11564683","citation_count":131,"is_preprint":false},{"pmid":"24106342","id":"PMC_24106342","title":"Heteromeric MT1/MT2 melatonin receptors modulate photoreceptor function.","date":"2013","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/24106342","citation_count":124,"is_preprint":false},{"pmid":"20200349","id":"PMC_20200349","title":"Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20200349","citation_count":124,"is_preprint":false},{"pmid":"30881340","id":"PMC_30881340","title":"Differential Function of Melatonin MT1 and MT2 Receptors in REM and NREM Sleep.","date":"2019","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30881340","citation_count":117,"is_preprint":false},{"pmid":"23971978","id":"PMC_23971978","title":"Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.","date":"2014","source":"Journal of psychiatry & neuroscience : JPN","url":"https://pubmed.ncbi.nlm.nih.gov/23971978","citation_count":115,"is_preprint":false},{"pmid":"19228178","id":"PMC_19228178","title":"Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.","date":"2009","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/19228178","citation_count":114,"is_preprint":false},{"pmid":"19377077","id":"PMC_19377077","title":"Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.","date":"2009","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/19377077","citation_count":96,"is_preprint":false},{"pmid":"21622652","id":"PMC_21622652","title":"Regulation of TMPRSS6 by BMP6 and iron in human cells and mice.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21622652","citation_count":94,"is_preprint":false},{"pmid":"28512916","id":"PMC_28512916","title":"Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway.","date":"2017","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/28512916","citation_count":94,"is_preprint":false},{"pmid":"25770211","id":"PMC_25770211","title":"Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25770211","citation_count":91,"is_preprint":false},{"pmid":"16203090","id":"PMC_16203090","title":"Impaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16203090","citation_count":91,"is_preprint":false},{"pmid":"21873547","id":"PMC_21873547","title":"TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21873547","citation_count":91,"is_preprint":false},{"pmid":"20966077","id":"PMC_20966077","title":"Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20966077","citation_count":87,"is_preprint":false},{"pmid":"8947294","id":"PMC_8947294","title":"Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant.","date":"1996","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/8947294","citation_count":84,"is_preprint":false},{"pmid":"30937953","id":"PMC_30937953","title":"MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations.","date":"2019","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/30937953","citation_count":81,"is_preprint":false},{"pmid":"21785125","id":"PMC_21785125","title":"Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21785125","citation_count":80,"is_preprint":false},{"pmid":"29149494","id":"PMC_29149494","title":"Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma.","date":"2018","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/29149494","citation_count":79,"is_preprint":false},{"pmid":"25599452","id":"PMC_25599452","title":"Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways.","date":"2015","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/25599452","citation_count":78,"is_preprint":false},{"pmid":"37564204","id":"PMC_37564204","title":"Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway.","date":"2023","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37564204","citation_count":77,"is_preprint":false},{"pmid":"17213040","id":"PMC_17213040","title":"Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease.","date":"2006","source":"European journal of histochemistry : EJH","url":"https://pubmed.ncbi.nlm.nih.gov/17213040","citation_count":77,"is_preprint":false},{"pmid":"10717416","id":"PMC_10717416","title":"Selective MT(2) melatonin receptor antagonist blocks melatonin-induced antinociception in rats.","date":"2000","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/10717416","citation_count":72,"is_preprint":false},{"pmid":"22980085","id":"PMC_22980085","title":"Melatonin suppresses apoptosis and stimulates progesterone production by bovine granulosa cells via its receptors (MT1 and MT2).","date":"2012","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/22980085","citation_count":72,"is_preprint":false},{"pmid":"24768045","id":"PMC_24768045","title":"Melatonin regulates the development and function of bovine Sertoli cells via its receptors MT1 and MT2.","date":"2014","source":"Animal reproduction science","url":"https://pubmed.ncbi.nlm.nih.gov/24768045","citation_count":62,"is_preprint":false},{"pmid":"25501601","id":"PMC_25501601","title":"The MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/25501601","citation_count":61,"is_preprint":false},{"pmid":"28580603","id":"PMC_28580603","title":"Enhancement of high glucose-induced PINK1 expression by melatonin stimulates neuronal cell survival: Involvement of MT2 /Akt/NF-κB pathway.","date":"2017","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/28580603","citation_count":59,"is_preprint":false},{"pmid":"16825197","id":"PMC_16825197","title":"TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16825197","citation_count":58,"is_preprint":false},{"pmid":"24966834","id":"PMC_24966834","title":"The role of TMPRSS6/matriptase-2 in iron regulation and anemia.","date":"2014","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24966834","citation_count":55,"is_preprint":false},{"pmid":"19818657","id":"PMC_19818657","title":"Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia.","date":"2009","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19818657","citation_count":53,"is_preprint":false},{"pmid":"28183259","id":"PMC_28183259","title":"Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain.","date":"2018","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28183259","citation_count":52,"is_preprint":false},{"pmid":"17316165","id":"PMC_17316165","title":"The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimer's disease.","date":"2007","source":"Current Alzheimer research","url":"https://pubmed.ncbi.nlm.nih.gov/17316165","citation_count":52,"is_preprint":false},{"pmid":"22301935","id":"PMC_22301935","title":"Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population.","date":"2012","source":"The American journal of clinical nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/22301935","citation_count":52,"is_preprint":false},{"pmid":"21459362","id":"PMC_21459362","title":"A new perspective in Oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity.","date":"2011","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/21459362","citation_count":51,"is_preprint":false},{"pmid":"24117008","id":"PMC_24117008","title":"Melatonin MT₁ and MT₂ receptors display different molecular pharmacologies only in the G-protein coupled state.","date":"2014","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24117008","citation_count":51,"is_preprint":false},{"pmid":"27103927","id":"PMC_27103927","title":"Circadian Pattern of Melatonin MT1 and MT2 Receptor Localization in the Rat Suprachiasmatic Nucleus.","date":"2015","source":"Journal of circadian rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/27103927","citation_count":49,"is_preprint":false},{"pmid":"25156943","id":"PMC_25156943","title":"Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies.","date":"2014","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/25156943","citation_count":49,"is_preprint":false},{"pmid":"7995974","id":"PMC_7995974","title":"MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance.","date":"1994","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/7995974","citation_count":48,"is_preprint":false},{"pmid":"23925449","id":"PMC_23925449","title":"Mammalian MT1 and MT2 metallothioneins differ in their metal binding abilities.","date":"2013","source":"Metallomics : integrated biometal science","url":"https://pubmed.ncbi.nlm.nih.gov/23925449","citation_count":45,"is_preprint":false},{"pmid":"28335493","id":"PMC_28335493","title":"Melatonin MT₁ and MT₂ Receptors in the Ram Reproductive Tract.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28335493","citation_count":44,"is_preprint":false},{"pmid":"35626727","id":"PMC_35626727","title":"Activation of MT1/MT2 to Protect Testes and Leydig Cells against Cisplatin-Induced Oxidative Stress through the SIRT1/Nrf2 Signaling Pathway.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35626727","citation_count":42,"is_preprint":false},{"pmid":"35689787","id":"PMC_35689787","title":"Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression.","date":"2022","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/35689787","citation_count":41,"is_preprint":false},{"pmid":"30706990","id":"PMC_30706990","title":"Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer's disease via C/EBPα/miR-125b pathway.","date":"2019","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/30706990","citation_count":41,"is_preprint":false},{"pmid":"23798576","id":"PMC_23798576","title":"Minireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23798576","citation_count":40,"is_preprint":false},{"pmid":"26334942","id":"PMC_26334942","title":"Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.","date":"2015","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26334942","citation_count":40,"is_preprint":false},{"pmid":"18384758","id":"PMC_18384758","title":"Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.","date":"2008","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18384758","citation_count":39,"is_preprint":false},{"pmid":"12510864","id":"PMC_12510864","title":"Role of endogenous melatonin and its MT2 receptor in the modulation of caerulein-induced pancreatitis in the rat.","date":"2002","source":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society","url":"https://pubmed.ncbi.nlm.nih.gov/12510864","citation_count":38,"is_preprint":false},{"pmid":"20704562","id":"PMC_20704562","title":"A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20704562","citation_count":37,"is_preprint":false},{"pmid":"29118419","id":"PMC_29118419","title":"Melatonin promotes triacylglycerol accumulation via MT2 receptor during differentiation in bovine intramuscular preadipocytes.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29118419","citation_count":37,"is_preprint":false},{"pmid":"12826274","id":"PMC_12826274","title":"Mutagenesis studies of the human MT2 melatonin receptor.","date":"2003","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12826274","citation_count":36,"is_preprint":false},{"pmid":"26162699","id":"PMC_26162699","title":"Antinociceptive properties of selective MT(2) melatonin receptor partial agonists.","date":"2015","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26162699","citation_count":35,"is_preprint":false},{"pmid":"24658816","id":"PMC_24658816","title":"The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.","date":"2014","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/24658816","citation_count":34,"is_preprint":false},{"pmid":"20738301","id":"PMC_20738301","title":"Genetic variability of TMPRSS6 and its association with iron deficiency anaemia.","date":"2010","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/20738301","citation_count":32,"is_preprint":false},{"pmid":"25557470","id":"PMC_25557470","title":"The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment.","date":"2015","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/25557470","citation_count":31,"is_preprint":false},{"pmid":"2904253","id":"PMC_2904253","title":"Entry of human immunodeficiency virus (HIV) into MT-2, human T cell leukemia virus carrier cell line.","date":"1988","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/2904253","citation_count":30,"is_preprint":false},{"pmid":"27374080","id":"PMC_27374080","title":"MT2-MMP induces proteolysis and leads to EMT in carcinomas.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27374080","citation_count":30,"is_preprint":false},{"pmid":"23332368","id":"PMC_23332368","title":"N-(Phenoxyalkyl)amides as MT(1) and MT(2) ligands: antioxidant properties and inhibition of Ca(2+)/CaM-dependent kinase II.","date":"2012","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23332368","citation_count":30,"is_preprint":false},{"pmid":"28827538","id":"PMC_28827538","title":"Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT2 receptor reciprocally modulate their signaling functions.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28827538","citation_count":30,"is_preprint":false},{"pmid":"19907145","id":"PMC_19907145","title":"Role of matriptase-2 (TMPRSS6) in iron metabolism.","date":"2009","source":"Acta haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/19907145","citation_count":29,"is_preprint":false},{"pmid":"24892818","id":"PMC_24892818","title":"Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor.","date":"2014","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/24892818","citation_count":29,"is_preprint":false},{"pmid":"21353709","id":"PMC_21353709","title":"Single nucleotide polymorphisms and mRNA expression for melatonin MT(2) receptor in depression.","date":"2011","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/21353709","citation_count":29,"is_preprint":false},{"pmid":"36690839","id":"PMC_36690839","title":"TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis.","date":"2023","source":"Advances in therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36690839","citation_count":28,"is_preprint":false},{"pmid":"31543462","id":"PMC_31543462","title":"Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes.","date":"2019","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/31543462","citation_count":28,"is_preprint":false},{"pmid":"32239546","id":"PMC_32239546","title":"Dysfunction of serotonergic activity and emotional responses across the light-dark cycle in mice lacking melatonin  MT2 receptors.","date":"2020","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/32239546","citation_count":28,"is_preprint":false},{"pmid":"12538005","id":"PMC_12538005","title":"Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands.","date":"2003","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12538005","citation_count":28,"is_preprint":false},{"pmid":"23541165","id":"PMC_23541165","title":"Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.","date":"2013","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/23541165","citation_count":28,"is_preprint":false},{"pmid":"22244935","id":"PMC_22244935","title":"Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6.","date":"2012","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22244935","citation_count":26,"is_preprint":false},{"pmid":"11068946","id":"PMC_11068946","title":"A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.","date":"2000","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/11068946","citation_count":26,"is_preprint":false},{"pmid":"20117087","id":"PMC_20117087","title":"The role of MT2-MMP in cancer progression.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20117087","citation_count":26,"is_preprint":false},{"pmid":"25046530","id":"PMC_25046530","title":"Genetic deletion of MT₁/MT₂ melatonin receptors enhances murine cognitive and motor performance.","date":"2014","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25046530","citation_count":26,"is_preprint":false},{"pmid":"29194702","id":"PMC_29194702","title":"The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease.","date":"2017","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/29194702","citation_count":25,"is_preprint":false},{"pmid":"22301214","id":"PMC_22301214","title":"Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).","date":"2012","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22301214","citation_count":25,"is_preprint":false},{"pmid":"30002300","id":"PMC_30002300","title":"The Mechanism of Melatonin and Its Receptor MT2 Involved in the Development of Bovine Granulosa Cells.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30002300","citation_count":25,"is_preprint":false},{"pmid":"21612955","id":"PMC_21612955","title":"Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6).","date":"2011","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21612955","citation_count":24,"is_preprint":false},{"pmid":"18544139","id":"PMC_18544139","title":"The role of proline residues in the structure and function of human MT2 melatonin receptor.","date":"2008","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/18544139","citation_count":23,"is_preprint":false},{"pmid":"18493743","id":"PMC_18493743","title":"Physiological states and energetic adaptation during growth of Pseudomonas putida mt-2 on glucose.","date":"2008","source":"Archives of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/18493743","citation_count":22,"is_preprint":false},{"pmid":"24376517","id":"PMC_24376517","title":"Inflammation regulates TMPRSS6 expression via STAT5.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24376517","citation_count":22,"is_preprint":false},{"pmid":"19193160","id":"PMC_19193160","title":"2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.","date":"2009","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19193160","citation_count":22,"is_preprint":false},{"pmid":"21724843","id":"PMC_21724843","title":"Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21724843","citation_count":22,"is_preprint":false},{"pmid":"24909617","id":"PMC_24909617","title":"Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer's disease.","date":"2014","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/24909617","citation_count":22,"is_preprint":false},{"pmid":"25704252","id":"PMC_25704252","title":"Identification of TMPRSS6 cleavage sites of hemojuvelin.","date":"2015","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25704252","citation_count":21,"is_preprint":false},{"pmid":"28377323","id":"PMC_28377323","title":"Brain injury results in lower levels of melatonin receptors subtypes MT1 and MT2.","date":"2017","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/28377323","citation_count":21,"is_preprint":false},{"pmid":"30979376","id":"PMC_30979376","title":"Higher melatonin in the follicle fluid and MT2 expression in the granulosa cells contribute to the OHSS occurrence.","date":"2019","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/30979376","citation_count":20,"is_preprint":false},{"pmid":"22202844","id":"PMC_22202844","title":"Molecular pharmacology of the mouse melatonin receptors MT₁ and MT₂.","date":"2011","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22202844","citation_count":20,"is_preprint":false},{"pmid":"33392634","id":"PMC_33392634","title":"MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression.","date":"2021","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/33392634","citation_count":19,"is_preprint":false},{"pmid":"25031779","id":"PMC_25031779","title":"MT2-MMP expression associates with tumor progression and angiogenesis in human lung cancer.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25031779","citation_count":19,"is_preprint":false},{"pmid":"28382516","id":"PMC_28382516","title":"Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells.","date":"2017","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/28382516","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48504,"output_tokens":3541,"usd":0.099313},"stage2":{"model":"claude-opus-4-6","input_tokens":7002,"output_tokens":2758,"usd":0.15594},"total_usd":0.255253,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"TMPRSS6 (matriptase-2) is required to sense iron deficiency and suppress hepcidin (Hamp) transcription; overexpression of normal TMPRSS6 suppresses activation of the Hamp promoter, and the TMPRSS6 cytoplasmic domain mediates Hamp suppression via proximal promoter elements. Loss-of-function (splicing defect) in mice causes microcytic anemia due to high hepcidin and reduced dietary iron absorption.\",\n      \"method\": \"Chemically induced mouse mutant (mask), overexpression of TMPRSS6, promoter assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational loss-of-function mouse model plus promoter functional assays, replicated in subsequent studies\",\n      \"pmids\": [\"18451267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TMPRSS6/matriptase-2 inhibits hepcidin activation by cleaving membrane hemojuvelin (HJV) at the plasma membrane; the serine protease domain is required for cleavage activity, the IRIDA patient mutant R774C shows decreased cleavage capacity, and the ectodomain of matriptase-2 mediates interaction with HJV.\",\n      \"method\": \"Cell-based cleavage assay, domain deletion mutants, patient mutant functional characterization, zebrafish overexpression\",\n      \"journal\": \"Cell Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro cleavage assays with domain mutants, multiple orthogonal methods, replicated across studies\",\n      \"pmids\": [\"18976966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A truncating TMPRSS6 mutation in humans causes inappropriately elevated hepcidin levels, leading to defective iron absorption and iron-refractory iron-deficiency anemia (IRIDA), confirming the inhibitory role of TMPRSS6 on hepcidin synthesis in humans.\",\n      \"method\": \"Linkage analysis, gene sequencing, serum/urinary hepcidin measurement in patients\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human genetic loss-of-function with functional hepcidin measurements, replicated independently\",\n      \"pmids\": [\"18603562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TMPRSS6 down-regulates the BMP-SMAD signaling pathway to control hepcidin expression; mice deficient in both Tmprss6 and hemojuvelin (Hjv) show markedly decreased hepcidin and Id1 mRNA and develop systemic iron overload similar to Hjv-deficient mice alone, placing Tmprss6 downstream of Hjv in the BMP/Smad pathway.\",\n      \"method\": \"Genetic epistasis in double-knockout mice (Tmprss6−/−/Hjv−/−), hepatic gene expression analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic epistasis with double-knockout mice and defined molecular readouts\",\n      \"pmids\": [\"20200349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TMPRSS6 expression is upregulated by hypoxia-inducible factors (HIF-1α and HIF-2α) in hepatic cell lines; HIF-dependent up-regulation of TMPRSS6 increases membrane HJV shedding and decreases hepcidin promoter responsiveness to BMP signaling.\",\n      \"method\": \"Hypoxia treatment of hepatic cell lines, HIF pathway activation/inhibition, HJV shedding assays, hepcidin promoter reporter assay\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in a single study, not yet independently replicated\",\n      \"pmids\": [\"20966077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A TMPRSS6 mutation (Y141C) in the SEA domain prevents autocatalytic self-activation of the protease; the mutant localizes normally and binds HJV but cannot auto-catalytically activate itself, resulting in increased hepcidin mRNA expression.\",\n      \"method\": \"Patient mutation characterization, cell transfection, subcellular localization, HJV binding assay, hepcidin mRNA measurement\",\n      \"journal\": \"The Biochemical Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mechanistic characterization of auto-activation with functional validation of catalytic consequence\",\n      \"pmids\": [\"20704562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TMPRSS6 undergoes constitutive clathrin/AP-2-dependent, dynamin-dependent endocytosis in hepatic cells; internalized TMPRSS6 transits through early endosomes to lysosomes. Mutations in the N-terminal cytoplasmic domain that block endocytosis keep TMPRSS6 at the cell surface, resulting in sustained HJV cleavage and significantly decreased hepcidin production.\",\n      \"method\": \"Cell surface labeling, co-localization with clathrin/AP-2 markers, dynamin inhibition, site-directed mutagenesis of cytoplasmic internalization signals, hepcidin promoter assay\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mechanistic dissection of internalization pathway with mutagenesis and functional hepcidin readout\",\n      \"pmids\": [\"21724843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BMP6 and iron stimulate TMPRSS6 expression at the mRNA and protein levels via the BMP-SMAD pathway, with inhibitor of DNA binding 1 (ID1) identified as the key downstream element; TMPRSS6 upregulation by BMP6/iron increases matriptase-2 activity, HJV cleavage, and reduces hepcidin promoter responsiveness—a negative feedback loop.\",\n      \"method\": \"BMP6 treatment in vitro, neutralizing antibody injection in mice, TMPRSS6 mRNA/protein/activity assays, chromatin and promoter analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in vitro and in vivo\",\n      \"pmids\": [\"21622652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The TMPRSS6 SNP rs855791 (V736A) is a functional variant: the 736A isoform inhibits hepcidin more efficiently than 736V in vitro and is associated with lower hepcidin levels and higher iron parameters in a genotyped population.\",\n      \"method\": \"In vitro overexpression of TMPRSS6 V736A vs V736V, hepcidin promoter assay, population genotyping with serum hepcidin measurements\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro functional assay combined with population phenotyping in one study\",\n      \"pmids\": [\"21873547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Inflammation down-regulates TMPRSS6 expression in vitro and in vivo through decreased STAT5 phosphorylation; STAT5 directly binds a STAT5 element on the Tmprss6 promoter and positively regulates its transcription. Loss of TMPRSS6 via this mechanism contributes to inflammation-induced hepcidin elevation.\",\n      \"method\": \"IL-6 treatment of hepatoma cells, LPS injection in mice, STAT5 ChIP and promoter binding assay, phosphorylation analysis\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding demonstrated by ChIP, validated in vitro and in vivo\",\n      \"pmids\": [\"24376517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TMPRSS6 cleaves hemojuvelin at arginine residues 121 and 326 in both the full-length and heterodimeric HJV isoforms; mutagenesis of these arginines abolishes or alters the cleavage fragment pattern, and molecular dynamics modeling supports their solvent-accessibility in the HJV structure.\",\n      \"method\": \"Site-directed mutagenesis of HJV arginine residues, co-expression with TMPRSS6, fragment analysis in conditioned media, molecular dynamics simulation\",\n      \"journal\": \"Journal of Cellular and Molecular Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — systematic mutagenesis of cleavage sites combined with structural modeling\",\n      \"pmids\": [\"25704252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"IRIDA patient missense mutations in TMPRSS6 impair matriptase-2 autocatalytic activation and/or its ability to cleave membrane HJV and inhibit HJV-dependent hepcidin activation; genotype-phenotype analysis shows patients with two nonsense mutations have more severe anemia and higher hepcidin than those with partial-loss mutations.\",\n      \"method\": \"In vitro expression of IRIDA patient mutants, autocatalytic activation assay, HJV cleavage assay, hepcidin promoter reporter assay, genotype-phenotype correlation in patients\",\n      \"journal\": \"Human Mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — systematic functional characterization of multiple patient mutations with multiple orthogonal assays\",\n      \"pmids\": [\"25156943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Deletion of Tmprss6 in Hbb(th3/+) β-thalassemia mice upregulates hepcidin, inhibits iron absorption and recycling, reduces ineffective erythropoiesis, splenomegaly, and iron loading; Tmprss6 is essential for hepcidin inhibition by the erythroid regulator in thalassemia.\",\n      \"method\": \"Double-knockout mouse model (Tmprss6−/−/Hbbth3/+), hematological and iron parameter analysis, hepcidin mRNA measurement\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic model with defined mechanistic and phenotypic readouts, independently replicated\",\n      \"pmids\": [\"22490684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Genetic epistasis shows that hepatic TFR2 acts upstream of TMPRSS6 in the hepcidin-regulation pathway; Hfe and Tfr2 are not substrates for Tmprss6 protease activity (double mutant mice show Tmprss6-phenotype dominance for hepcidin), while erythroid Tfr2 modulates erythropoiesis independently of hepcidin.\",\n      \"method\": \"Double-knockout mouse models (Tmprss6−/−/Tfr2−/− and Tmprss6−/−/Tfr2LCKO), hepcidin and iron parameter analysis\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with tissue-specific knockout mice and defined pathway placement\",\n      \"pmids\": [\"24658816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Peptidomimetic and non-peptidic inhibitors of TMPRSS6 block TMPRSS6-dependent hemojuvelin cleavage in hepatocytes and increase HAMP expression and secreted hepcidin levels in HepG2 cells and human primary hepatocytes.\",\n      \"method\": \"TMPRSS6 inhibitor treatment of hepatic cell lines and primary hepatocytes, HJV cleavage assay, hepcidin mRNA and protein measurement\",\n      \"journal\": \"Cell Chemical Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic inhibition with mechanistic substrate (HJV) cleavage readout in human primary cells\",\n      \"pmids\": [\"31543462\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TMPRSS6 (matriptase-2) is a type II transmembrane serine protease expressed primarily in hepatocytes that autocatalytically activates itself and then cleaves membrane hemojuvelin (at Arg121 and Arg326) via dynamin-dependent, clathrin-mediated endocytic cycling at the cell surface, thereby disrupting BMP-SMAD signaling and suppressing transcription of the iron-regulatory hormone hepcidin; its expression is positively regulated by BMP6/iron (via SMAD/ID1) and growth hormone (via STAT5), and negatively regulated by inflammation (via reduced STAT5 phosphorylation), placing TMPRSS6 as the central brake on hepcidin production that permits adequate dietary iron absorption during iron deficiency.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TMPRSS6 (matriptase-2) is a hepatocyte-expressed type II transmembrane serine protease that functions as the principal negative regulator of hepcidin, the master hormone controlling systemic iron homeostasis. TMPRSS6 undergoes autocatalytic self-activation requiring an intact SEA domain, then cleaves membrane hemojuvelin (HJV) at Arg121 and Arg326, thereby disrupting BMP-SMAD signaling and suppressing hepcidin (HAMP) transcription [PMID:18976966, PMID:25156943, PMID:25704252]. The protease cycles through the plasma membrane via clathrin/AP-2- and dynamin-dependent endocytosis to lysosomes; blocking internalization prolongs surface residence and enhances HJV cleavage [PMID:21724843]. Its expression is induced by BMP6/iron through SMAD/ID1 as a negative-feedback loop and by STAT5, while inflammation suppresses TMPRSS6 via reduced STAT5 phosphorylation; loss-of-function mutations cause iron-refractory iron-deficiency anemia (IRIDA) in humans [PMID:21622652, PMID:24376517, PMID:18603562].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of TMPRSS6 as the critical sensor of iron deficiency that suppresses hepcidin transcription resolved how the body permits dietary iron absorption under low-iron conditions; loss of function causes microcytic anemia from unchecked hepcidin production.\",\n      \"evidence\": \"Forward genetic screen in ENU-mutagenized mice (mask phenotype), overexpression and promoter assays\",\n      \"pmids\": [\"18451267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular substrate of TMPRSS6 not yet identified at this stage\", \"Mechanism of hepcidin promoter suppression unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstration that TMPRSS6 cleaves membrane hemojuvelin via its serine protease domain identified the direct substrate linking the protease to BMP-SMAD-hepcidin signaling, and showed that IRIDA mutations impair this cleavage.\",\n      \"evidence\": \"Cell-based HJV cleavage assay with domain-deletion and patient (R774C) mutants, zebrafish overexpression\",\n      \"pmids\": [\"18976966\", \"18603562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific cleavage sites on HJV not mapped\", \"In vivo confirmation of HJV as the sole relevant substrate not established\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Genetic epistasis placing TMPRSS6 downstream of HJV in the BMP-SMAD pathway clarified that the protease acts by eliminating a required BMP co-receptor rather than signaling independently.\",\n      \"evidence\": \"Double-knockout mice (Tmprss6−/−/Hjv−/−) with hepatic gene expression profiling\",\n      \"pmids\": [\"20200349\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TMPRSS6 cleaves additional BMP pathway components not resolved\", \"Contribution of soluble HJV fragments to residual signaling unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that the SEA-domain IRIDA mutation Y141C abolishes autocatalytic activation while preserving HJV binding established that self-activation is a prerequisite for substrate cleavage and a distinct mechanistic step.\",\n      \"evidence\": \"Patient mutant characterization with subcellular localization, HJV binding, and hepcidin mRNA assays in transfected cells\",\n      \"pmids\": [\"20704562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of autocatalytic cleavage not determined\", \"Whether additional cofactors assist activation unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Elucidation of constitutive clathrin/AP-2/dynamin-dependent endocytosis of TMPRSS6 showed that intracellular trafficking limits cell-surface lifetime of the protease and thereby tunes the magnitude of HJV cleavage and hepcidin suppression.\",\n      \"evidence\": \"Surface labeling, colocalization with clathrin/AP-2 markers, dynamin inhibition, cytoplasmic domain mutagenesis, hepcidin promoter assays in hepatic cells\",\n      \"pmids\": [\"21724843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific internalization motif(s) in cytoplasmic tail not fully mapped\", \"Whether endosomal TMPRSS6 retains catalytic activity not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"BMP6/iron-driven upregulation of TMPRSS6 via SMAD/ID1 revealed a negative-feedback loop: the same signal that induces hepcidin also amplifies its suppressor, explaining how hepcidin is fine-tuned rather than simply switched on.\",\n      \"evidence\": \"BMP6 treatment in vitro, anti-BMP6 antibody injection in mice, TMPRSS6 mRNA/protein/activity assays, promoter analysis\",\n      \"pmids\": [\"21622652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of feedback loop to steady-state hepcidin levels in vivo not modeled\", \"Whether other BMP ligands contribute similarly unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Deletion of Tmprss6 in β-thalassemia mice showed that the protease is required for pathological hepcidin suppression by the expanded erythroid compartment, establishing TMPRSS6 as a therapeutic target for iron-loading anemias.\",\n      \"evidence\": \"Double mutant mice (Tmprss6−/−/Hbbth3/+), hematological, iron, and hepcidin analysis\",\n      \"pmids\": [\"22490684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nature of the erythroid signal that acts through TMPRSS6 not identified\", \"Degree of hepcidin restoration needed for therapeutic benefit not quantified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of STAT5 as a direct positive transcriptional regulator of TMPRSS6, suppressed during inflammation via reduced STAT5 phosphorylation, explained how inflammatory signals elevate hepcidin partly by removing the TMPRSS6 brake.\",\n      \"evidence\": \"IL-6 treatment of hepatoma cells, LPS injection in mice, STAT5 ChIP on Tmprss6 promoter, phosphorylation analysis\",\n      \"pmids\": [\"24376517\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of TMPRSS6 down-regulation versus direct IL-6/STAT3-driven hepcidin induction during inflammation not dissected\", \"Growth hormone/STAT5 axis regulation of TMPRSS6 in vivo not independently confirmed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Systematic functional analysis of IRIDA mutations showed that missense variants impair either autocatalytic activation or HJV cleavage or both, and that genotype severity correlates with phenotype, solidifying the structure-function framework for clinical genetics.\",\n      \"evidence\": \"In vitro expression of multiple patient mutants, autocatalytic activation, HJV cleavage, and hepcidin promoter reporter assays, genotype-phenotype correlation\",\n      \"pmids\": [\"25156943\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of TMPRSS6 protease domain not available to map mutation effects structurally\", \"Residual activity thresholds for clinical disease not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mapping HJV cleavage to Arg121 and Arg326 defined the precise sites through which TMPRSS6 inactivates the BMP co-receptor, providing the first substrate-level resolution.\",\n      \"evidence\": \"Systematic arginine-to-alanine mutagenesis of HJV, fragment analysis in conditioned media, molecular dynamics simulation\",\n      \"pmids\": [\"25704252\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether these are the only physiologically relevant cleavage sites in vivo not confirmed\", \"Kinetic parameters of cleavage not measured\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Small-molecule inhibitors of TMPRSS6 recapitulated loss-of-function effects—blocking HJV cleavage and raising hepcidin—in human primary hepatocytes, providing pharmacological proof of concept for targeting the protease.\",\n      \"evidence\": \"Peptidomimetic and non-peptidic inhibitor treatment of HepG2 cells and human primary hepatocytes, HJV cleavage and hepcidin assays\",\n      \"pmids\": [\"31543462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo efficacy and selectivity of inhibitors not demonstrated\", \"Off-target effects on other TTSP family members not assessed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution crystal structure of TMPRSS6, the complete repertoire of physiological substrates beyond HJV, and the identity of the erythroid signal that acts through TMPRSS6 in ineffective erythropoiesis remain to be established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of TMPRSS6\", \"Whether substrates other than HJV contribute to hepcidin regulation is unresolved\", \"Identity of erythroid factor that requires TMPRSS6 for hepcidin suppression is unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 5, 10, 11, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 5, 6]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 7]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 2, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"HFE2\",\n      \"STAT5A\",\n      \"SMAD4\",\n      \"ID1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}